News | Page 55 | Weill Department of Medicine

Dr. Melnick and Team Publish Pivotal Paper in Cell Reports: Stage Set for Clinical Trials Using Experimental New Drug for Lymphoma (DLBCL)

On the heels of numerous advancements by the Melnick Lab, the latest breakthrough involves an experimental new drug that is capable of completely eradicating human lymphoma in mice after five doses. Published in Cell Reports (August 2013), this finding sets the stage for clinical trials that would use an experimental drug for the treatment of B-cell lymphoma (DLBCL). Dr. Ari Melnick, who joined the Division of Hematology and Medical Oncology in 2008, established that Bcl6 is a master regulatory... Read More

Weill Cornell Community Clinic (WCCC) Welcomes Dr. Pamela Charney as Medical Director

Dr. Pamela CharneyRecognized for her ongoing service in community-based medicine, Dr. Charney has joined the WCCC as its new clinical director. In this role, she will work extensively with the student clinical directors of this Weill Cornell student-based initiative that operates out of WCIMA and provides valuable patient care to individuals who are under- or uninsured. Dr. Charney is a Professor of Clinical Medicine at Weill Cornell and an Attending Physician at NewYork-Presbyterian Hospital.... Read More

Dr. Roboz Leads New Trials for MDS: First-Time Use of AQD Drug for MDS in a Clinical Trial

Dr. Gail RobozDr. Gail Roboz, Associate Professor of Medicine and Director of the Leukemia Program at NYP/WC, has been named lead investigator for a Sunesis Pharmaceuticals-funded clinical trial for the treatment of myelodysplastic syndrome (MDS). A Phase I/II (open-label, dose escalating) trial, it is set to enroll approximately 40 patients with MDS who previously experienced failed treatment using hypomethylating agent-based therapy. Using an AQD (anti-cancer quinolone derivative) drug (... Read More

Study Recently Published in Cancer Discovery Reveals New Epigenetic Pathway That Allows Chemotherapy to Kill Cancer

Dr. Cerchietti in the laboratoryChemoresistant diffuse large B-cell lymphoma (DLBCL) is a devastating illness that affects thousands of people each year in the United Stats, but there is good news to report. Dr. Leandro Cerchietti and Dr. Peter Martin, both members of the Division of Hematology and Medical Oncology, published a paper in Cancer Discovery in September 2013 that sheds light on the mechanisms by which DLBCL becomes resistant to chemotherapy and how those changes might be reversed.... Read More

Dr. Kahaleh and Team Establish New Technique for Diagnosing and Treating Conditions of the Biliary or Pancreatic Ductal System for Pregnant Women

Dr. Michel Kahaleh (far left) with colleagues in an endoscopy suiteIn pregnant women, the diagnostic and therapeutic techniques used for gall stones, strictures, obstructions, or other conditions within the biliary or pancreatic ductal systems, has been problematical due to exposure to radiation for the mother and the fetus. Dr. Michel Kahaleh, Division of Gastroenterology and Hepatology, and his team have successfully modified the diagnostic technique, endoscopic retrograde... Read More

Star Performer and Other Outstanding Employees Honored in the DOM

Dr. Ira Jacobson and Diana PierreThe Employee Recognition Review Committee (R3) of the Department of Medicine (DOM) completed its bimonthly review of all nominees. The program, which honors outstanding service by DOM employees, named Diana Pierre, Senior Medical Secretary, Division of Gastroenterology and Hepatology, as the top "Star Performer" of this review cycle. Known for her professional and effective manner in working with colleagues, physicians, and patients alike for more than 10 years... Read More

New State-of-the-Art Hypertension Center Opens at Weill Cornell

Dr. Mark S. Pecker, Professor of Clinical Medicine, and Dr. Samuel J. Mann, Professor of Clinical Medicine, were joined by Dr. Phyllis August, the Ralph A. Baer Professor of Medical Research, and other colleagues to celebrate the clinical expansion of a state-of-the-art hypertension unit located on 70th Street between York and First Avenue. Drs. Mann and Pecker will serve as the co-leaders for the new center. The 2,800-square-foot-center will fill a unique niche, in that it is one of very few... Read More

Meet the PEAC Team

L to R: Drs. Friedman and HorowitzDrs. Oren A. Friedman and James M. Horowitz, Division of Pulmonary-Critical Care and Cardiology respectively, have recently published a paper in Endovascular Today (July 2013) on building a pulmonary embolism multidisciplinary team. The new PEAC, or Pulmonary Embolism Advanced Care team, is emerging at NYP/WC due to their efforts and Drs. Akhi Sista of interventional radiology and Arash Salemi of cardiothoracic surgery. The paper discusses the evolution of... Read More

Suthanthiran Team Achieves Yet Another Landmark Advancement for Kidney Transplantation

Members of the Suthanthiran laboratoryOn the heels of a series of advancements by the Suthanthiran Lab, the team has published a landmark paper in the New England Journal of Medicine (NEJM) showing that a urine biomarker test which they have devised in the lab, can not only diagnose, but predict, rejection of transplanted kidneys. This groundbreaking development may allow physicians to predict "weeks in advance," says Dr. Manikkam Suthanthiran (Chief, Division of Nephrology and Hypertension)... Read More

2013 Finalists for the Department of Medicine Investigator Award Announced

L to R: Drs. Joseph Scandura, Darshana Dadhania, Andrew Schafer, Ype de JongThe 2013 Department of Medicine Investigator Award finalists were announced and their talks were delivered during Grand Rounds on June 25, 2013. Dr. Joseph M. Scandura, was the winner and Drs. Darshana Dadhania and Ype P. de Jong were the runners-up. This was the 22nd annual presentation of the DOM Investigator Award, which is presented to members of the Department of Medicine, below the rank of professor, who perform... Read More